M. Akers

发表

Development and Manufacture of Protein Pharmaceuticals

S. Nail, M. Akers, 2002, Pharmaceutical Biotechnology.

Sterile Drug Products: Formulation, Packaging, Manufacturing and Quality

M. Akers, 2010 .

M. Akers, 1986 .

Rapid determination of dry layer mass transfer resistance for various pharmaceutical formulations during primary drying using product temperature profiles.

Lisa M. Hardwick, Lisa M Hardwick, W. Kuu, 2006, International journal of pharmaceutics.

Formulation design and development of parenteral suspensions.

R. Robison, M. Akers, A. L. Fites, 1987, Journal of parenteral science and technology : a publication of the Parenteral Drug Association.

The physical state of mannitol after freeze-drying: effects of mannitol concentration, freezing rate, and a noncrystallizing cosolute.

S. Nail, M. Akers, A. I. Kim, 1998, Journal of pharmaceutical sciences.

Sample chapter from Remington : Essentials of Pharmaceutics Chapter 26 Parenteral Preparations

M. Akers, 2013 .

Formulation development of protein dosage forms.

V. Vasudevan, M. Akers, M. Stickelmeyer, 2002, Pharmaceutical biotechnology.

Excipient-drug interactions in parenteral formulations.

Michael J Akers, M. Akers, 2002, Journal of pharmaceutical sciences.

Solubility principles and practices for parenteral drug dosage form development.

S Sweetana, M J Akers, S. Sweetana, 1996, PDA journal of pharmaceutical science and technology.

Glycine Crystallization During Freezing: The Effects of Salt Form, pH, and Ionic Strength

S. Byrn, N. Milton, S. Nail, 1995, Pharmaceutical Research.

Preformulation method for parenteral preservative efficacy evaluation.

A. Boand, M. Akers, D. Binkley, 1984, Journal of pharmaceutical sciences.

Pharmaceutical Development and Technology (PDT) announcements

M. Akers, 2012, Pharmaceutical development and technology.

Practical Aspects of Ophthalmic Drug Devlopment

J. Mcginity, R. Schoenwald, M. Akers, 1977 .

Antioxidants in pharmaceutical products.

M. Akers, 1982, Journal of parenteral science and technology : a publication of the Parenteral Drug Association.

Practical Formulation and Process Development of Freeze-Dried Products

Michael J Akers, Lisa M. Hardwick, Lisa M Hardwick, 2005, Pharmaceutical development and technology.

Practical fundamentals of glass, rubber, and plastic sterile packaging systems

Michael J Akers, Gregory A Sacha, Wendy Saffell-Clemmer, 2010, Pharmaceutical development and technology.

Sterility testing of antimicrobial-containing injectable solutions prepared in the pharmacy.

M. Akers, G. Wright, K. Carlson, 1991, American journal of hospital pharmacy.

Observation and Mitigation of Lamellar Silica Particles Formed in Pharmaceutical Products Packaged in Glass Vials.

J. Wypych, S. Moore, D. Dolan, 2022, Journal of pharmaceutical sciences.

An Evaluation of the Glass Vial Hydrolytic Resistance Method

Yasser Nashed-Samuel, M. Akers, Joseph Phillips, 2018, PDA Journal of Pharmaceutical Science and Technology.

Parenteral Quality Control: Sterility, Pyrogen, Particulate, and Package Integrity Testing

Michael Akers, Daniel Larrimore, Dana Morton Guazzo, 2002 .

Evaluation of emulsion stability by diffuse reflectance spectroscopy.

M. Akers, J. Lach, 1976, Journal of pharmaceutical sciences.

Alterations in absorption of dicumarol by various excipient materials.

L. J. Fischer, M. Akers, J. Lach, 1973, Journal of pharmaceutical sciences.

Sterile Filtration.

M. Akers, 2015, International journal of pharmaceutical compounding.

Parenteral fundamentals. Dynamics of microbial growth and death in parenteral products.

M. Akers, 1979, Journal of the Parenteral Drug Association.

Correlation of laboratory and production freeze drying cycles.

Michael J Akers, Lisa M. Hardwick, Wei Y Kuu, 2005, International journal of pharmaceutics.

Preformulation screening of antioxidant efficiency in parenteral solutions.

M. Akers, 1979, Journal of the Parenteral Drug Association.

Acute and long-term stability studies of deoxy hemoglobin and characterization of ascorbate-induced modifications.

I. Apostol, B. Kerwin, A. Mathews, 1999, Journal of pharmaceutical sciences.

Bioavailability of dicumarol from different commercial tablets in dogs.

L. J. Fischer, M. Akers, J. Lach, 1973, Journal of pharmaceutical sciences.

14 – Sterile Formulation

Michael J. Akers, Curtis S. Strother, Mark Robert Walden, 1996 .

The degradation of the antitumor agent gemcitabine hydrochloride in an acidic aqueous solution at pH 3.2 and identification of degradation products.

S. Baertschi, S. Maple, M. Akers, 2000, Journal of pharmaceutical sciences.

Mechanistic studies of glass vial breakage for frozen formulations. I. Vial breakage caused by crystallizable excipient mannitol.

F. Jameel, E. Freund, Manpreet-Vick S Wadhwa, 2007, PDA journal of pharmaceutical science and technology.

Drug stabilization against oxidative degradation

M. Akers, 1985 .

Peptides and Proteins as Parenteral Suspensions: An Overview of Design, Development, and Manufacturing Considerations

M. Akers, M. Defelippis, 2012 .

F Value Requirements for the Destruction of Endotoxin in the Validation of Dry Heat Sterilization/Depyrogenation Cycles

M. Akers, B. Thompson, Kathryn M. Ketron, 1982 .

Pelvic Inflammatory Disease: Spectrum of Imaging Findings

H. Ojeda-Fournier, M. Akers, 2006 .